ChromaDex (CDXC) Tops Q3 EPS by 2c

ChromaDex (NASDAQ: CDXC) reported Q3 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $20.3 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
• Creatd files Form S-1 and reports Q1 2026 financial results